PerspectiveRegulatory Science

Regulating 3D-printed medical products

See allHide authors and affiliations

Science Translational Medicine  03 Oct 2018:
Vol. 10, Issue 461, eaan6521
DOI: 10.1126/scitranslmed.aan6521

Article Information

vol. 10 no. 461

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication May 16, 2017
  • Resubmitted March 28, 2018
  • Accepted for publication September 12, 2018
  • .

Author Information

  1. Laura M. Ricles1,2,
  2. James C. Coburn3,
  3. Matthew Di Prima3 and
  4. Steven S. Oh1,*
  1. 1U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Tissues and Advanced Therapies, Silver Spring, MD 20993, USA.
  2. 2U.S. Food and Drug Administration, Office of the Commissioner, Commissioner’s Fellowship Program, Silver Spring, MD 20993, USA.
  3. 3U.S. Food and Drug Administration, Center for Device and Radiological Health, Office of Science and Engineering Laboratories, Silver Spring, MD 20993, USA.
  1. *Corresponding author. Email: steven.oh{at}fda.hhs.gov

Altmetric

Article usage

Article usage: October 2018 to November 2019

AbstractFullPdf
Oct 20183341670317
Nov 201826212549
Dec 20181695430
Jan 20191945029
Feb 20192383634
Mar 20191933935
Apr 20193435736
May 20191964217
Jun 20191082418
Jul 20191212215
Aug 20191132830
Sep 2019791612
Oct 20191282619
Nov 2019592812